AR065138A1 - Uso de compuestos de arsenico para el tratamiento del dolor y la inflamacion - Google Patents
Uso de compuestos de arsenico para el tratamiento del dolor y la inflamacionInfo
- Publication number
- AR065138A1 AR065138A1 ARP080100429A ARP080100429A AR065138A1 AR 065138 A1 AR065138 A1 AR 065138A1 AR P080100429 A ARP080100429 A AR P080100429A AR P080100429 A ARP080100429 A AR P080100429A AR 065138 A1 AR065138 A1 AR 065138A1
- Authority
- AR
- Argentina
- Prior art keywords
- arsenic
- pain
- treatment
- therapeutically effective
- hexoxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Abstract
Uso de compuestos de arsénico tales como meta arsenito de sodio (NaAsO2), trioxido de arsénico (As2O3) y/o hexoxido de arsénico (As4O6) o combinaciones de los mismos, para el tratamiento de los trastornos dolorosos, hiperalgésicos y/o inflamatorios. La presente se relaciona asimismo con composiciones que contienen los mencionados compuestos de arsénico para usar en el tratamiento del dolor, la inflamacion y enfermedades o trastornos inmunologicos y autoinmunes. Reivindicacion 19: El uso de un compuesto de arsénico seleccionado entre meta arsenito de sodio, trioxido de arsénico y/o hexoxido de arsénico en la elaboracion de una composicion inmunosupresora para el tratamiento del rechazo de tejidos u organos en un mamífero. Reivindicacion 20: Un kit que comprende por lo menos una cantidad de dosis terapéuticamente efectiva de un compuesto de arsénico seleccionado entre meta arsenito de sodio, trioxido de arsénico y/o hexoxido de arsénico y combinaciones de los mismos, donde la cantidad terapéuticamente efectiva del compuesto de arsénico es suficiente para reducir o prevenir el dolor en un animal objetivo y, optativamente, por lo menos una dosis de una cantidad terapéuticamente efectiva de un agente para el tratamiento del dolor, donde dicho agente para el tratamiento del dolor es un compuesto no arsénico.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89900707P | 2007-02-02 | 2007-02-02 | |
| US12/068,006 US8945505B2 (en) | 2007-02-02 | 2008-01-31 | Use of arsenic compounds for treatment of pain and inflammation |
| PCT/US2008/052751 WO2008097824A2 (en) | 2007-02-02 | 2008-02-01 | Use of arsenic compounds for treatment of pain and inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR065138A1 true AR065138A1 (es) | 2009-05-20 |
Family
ID=39322911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080100429A AR065138A1 (es) | 2007-02-02 | 2008-02-01 | Uso de compuestos de arsenico para el tratamiento del dolor y la inflamacion |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8945505B2 (es) |
| EP (1) | EP2114419B8 (es) |
| JP (3) | JP5411709B2 (es) |
| KR (1) | KR101479519B1 (es) |
| CN (2) | CN103550253A (es) |
| AR (1) | AR065138A1 (es) |
| AU (1) | AU2008214084C9 (es) |
| BR (1) | BRPI0807154B8 (es) |
| CA (3) | CA2677388C (es) |
| DK (1) | DK2114419T3 (es) |
| ES (1) | ES2460868T3 (es) |
| HK (1) | HK1138512A1 (es) |
| IL (3) | IL200173A (es) |
| MX (1) | MX2009008174A (es) |
| NZ (1) | NZ578621A (es) |
| PL (1) | PL2114419T3 (es) |
| RU (3) | RU2468806C2 (es) |
| TW (1) | TWI404538B (es) |
| WO (1) | WO2008097824A2 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090061022A1 (en) * | 2004-10-08 | 2009-03-05 | Sang Bong Lee | Pharmaceutical composition comprising arsenite for the treatment of malignancy |
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US8045505B2 (en) * | 2007-01-18 | 2011-10-25 | Science Applications International Corporation | Mechanism for automatic network formation and medium access coordination |
| EP2265287B1 (en) | 2008-03-04 | 2018-09-05 | Teva Pharmaceuticals International GmbH | Methods of treating chronic pain |
| WO2010133087A1 (en) * | 2009-05-18 | 2010-11-25 | The University Of Hong Kong | Compositions and methods for treating inflammatory arthritis |
| EP2470207A1 (en) | 2009-08-28 | 2012-07-04 | Rinat Neuroscience Corporation | Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| PL2475362T3 (pl) * | 2009-09-10 | 2019-09-30 | Kominox, Inc. | Terapia celowana w nowotworowe komórki macierzyste i raka lekoopornego |
| FR3004949B1 (fr) * | 2013-04-26 | 2016-02-05 | Centre Nat Rech Scient | Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| JP6568099B2 (ja) | 2014-03-21 | 2019-08-28 | テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーＴｅｖａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ | カルシトニン遺伝子関連ペプチドに対するアンタゴニスト抗体及びその使用方法 |
| KR102015858B1 (ko) * | 2015-10-23 | 2019-08-30 | 손영태 | 법제된 비상을 함유하는 면역력 증강을 위한 약학적 조성물 |
| KR20220031944A (ko) | 2016-09-23 | 2022-03-14 | 테바 파마슈티컬스 인터내셔널 게엠베하 | 불응성 편두통의 치료 |
| KR101844049B1 (ko) | 2016-12-05 | 2018-03-30 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 간암 예방 또는 치료용 약학 조성물 |
| KR101844050B1 (ko) * | 2016-12-09 | 2018-05-14 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물 |
| CN106890353A (zh) * | 2017-03-31 | 2017-06-27 | 应剑波 | 一种具有抗菌滋养功能的医用辅料 |
| US10716807B2 (en) * | 2017-05-09 | 2020-07-21 | Medsenic | Method of treating relapsing-remitting multiple sclerosis using arsenic trioxide |
| JOP20200238A1 (ar) * | 2018-03-22 | 2020-09-20 | Panaphix Inc | تركيبة صيدلانية وطريقة التصنيع |
| RU2687599C1 (ru) * | 2018-11-22 | 2019-05-15 | Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) | Способ лечения постмастэктомического синдрома |
| CN109674817B (zh) * | 2019-01-31 | 2021-06-29 | 哈尔滨医科大学 | 三氧化二砷在制备治疗晚期动脉粥样硬化药物中的用途 |
| AU2021219576A1 (en) * | 2020-02-16 | 2022-09-15 | Komipharm International Australia Pty Ltd | Method of treatment using meta-arsenite |
| RU2755329C2 (ru) * | 2020-03-13 | 2021-09-15 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ ИМЕНИ АКАДЕМИКА А.М. ГРАНОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ /ФГБУ "РНЦРХТ им. академика А.М. Гранова" Минздрава России | Способ лечения нерезектабельной гилюсной холангиокарциномы |
| US20230149453A1 (en) * | 2020-04-03 | 2023-05-18 | Medsenic | Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune/inflammatory diseases in humans or animals |
| EP3988093A1 (en) * | 2020-10-22 | 2022-04-27 | Medsenic | Use of an arsenic compound for treating a cytokine storm |
| KR102240693B1 (ko) * | 2020-05-18 | 2021-04-15 | 주식회사 케마스 | 육산화사비소를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학조성물 |
| KR20220020633A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 탈모방지 또는 발모촉진용 주사제 조성물 |
| KR20220020637A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물 |
| AU2021400745A1 (en) | 2020-12-17 | 2023-07-20 | Vertex Pharmaceuticals Incorporated | Compositions and methods for editing beta-globin for treatment of hemaglobinopathies |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US536273A (en) * | 1895-03-26 | Tavus rein | ||
| US1498639A (en) * | 1919-12-02 | 1924-06-24 | David S Pratt | Arsenical composition and method of making same |
| US3622664A (en) * | 1968-11-21 | 1971-11-23 | John A Brown | Treatment of infectious keratitis in animals with sodium arsenite |
| SU955909A1 (ru) * | 1980-06-25 | 1982-09-07 | Центральный Ордена Ленина Институт Усовершенствования Врачей | Способ профилактики осложнений при пересадке тканей |
| US4677974A (en) * | 1985-09-30 | 1987-07-07 | David Leonardi | Method and apparatus for immobilizing an eyelid |
| CA2051012C (en) | 1990-09-14 | 2002-04-02 | David R. Borcherding | Carbocyclic adenosine analogs useful as immunosupressants |
| ITTO930510A1 (it) | 1993-07-09 | 1993-10-07 | Walter Tarello | Farmaci attivi contro la chronic fatigue syndrome (c.f.s.) |
| CA2183547C (en) | 1994-02-18 | 2002-05-14 | Tamara Vasilievna Vorobieva | Compositions for treating defective cell functions |
| US5362735A (en) * | 1994-02-23 | 1994-11-08 | Smithkline Beecham Corporation | Rapamycin derivatives |
| IT1272994B (it) * | 1994-05-25 | 1997-07-01 | Giampiero Valletta | Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.- |
| IT1295067B1 (it) * | 1997-09-25 | 1999-04-27 | Walter Tarello | Uso di arsenico per preparare un medicamento per il trattamento della sindrome premestruale |
| EP1374875A3 (en) | 1997-10-15 | 2004-01-07 | Polarx Biopharmaceuticals, Inc. | Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| KR20020083678A (ko) * | 2001-04-28 | 2002-11-04 | 주식회사 한국미생물연구소 | 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물 |
| TW200408407A (en) * | 2001-11-30 | 2004-06-01 | Dana Farber Cancer Inst Inc | Methods and compositions for modulating the immune system and uses thereof |
| AR038377A1 (es) * | 2002-02-08 | 2005-01-12 | Merck & Co Inc | Derivados de n-bifenil-aminocicloalcancarboxamida (con sustitucion con metilo) |
| DK1496918T3 (da) | 2002-04-10 | 2023-05-15 | Komipharm Int Co Ltd | Anvendelse af natriummetaarsenit til behandling af tumorer |
| RU2310460C2 (ru) * | 2002-04-10 | 2007-11-20 | Корея Микробиолоджикал Лабораторис, Лтд. | Фармацевтическая композиция для лечения злокачественной опухоли, содержащая арсенит натрия |
| FR2838965B1 (fr) * | 2002-04-26 | 2004-06-25 | Centre Nat Rech Scient | Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme |
| JP2005206591A (ja) * | 2003-12-25 | 2005-08-04 | Mitsubishi Pharma Corp | 神経因性疼痛の予防及び／又は治療のための医薬 |
| US20080096872A1 (en) * | 2004-12-22 | 2008-04-24 | Friedman Robert S | Composition for Treatment of Pain Specification |
| JP2006206461A (ja) | 2005-01-26 | 2006-08-10 | Teizo Chinen | アレルギー疾患の予防・治療用組成物 |
| WO2006104292A1 (en) * | 2005-03-31 | 2006-10-05 | Komipharm International Co., Ltd. | Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts |
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US20060292243A1 (en) * | 2005-06-24 | 2006-12-28 | Shao-Chi Hsin | Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases |
-
2008
- 2008-01-31 US US12/068,006 patent/US8945505B2/en active Active
- 2008-02-01 WO PCT/US2008/052751 patent/WO2008097824A2/en active Application Filing
- 2008-02-01 RU RU2009132951/15A patent/RU2468806C2/ru active
- 2008-02-01 EP EP08714162.8A patent/EP2114419B8/en active Active
- 2008-02-01 KR KR1020097018389A patent/KR101479519B1/ko active IP Right Grant
- 2008-02-01 ES ES08714162.8T patent/ES2460868T3/es active Active
- 2008-02-01 PL PL08714162T patent/PL2114419T3/pl unknown
- 2008-02-01 DK DK08714162.8T patent/DK2114419T3/da active
- 2008-02-01 CN CN201310522816.6A patent/CN103550253A/zh active Pending
- 2008-02-01 RU RU2012134218A patent/RU2630574C2/ru active
- 2008-02-01 BR BRPI0807154A patent/BRPI0807154B8/pt active IP Right Grant
- 2008-02-01 CA CA2677388A patent/CA2677388C/en active Active
- 2008-02-01 CA CA2845299A patent/CA2845299C/en active Active
- 2008-02-01 MX MX2009008174A patent/MX2009008174A/es active IP Right Grant
- 2008-02-01 NZ NZ578621A patent/NZ578621A/en unknown
- 2008-02-01 JP JP2009548463A patent/JP5411709B2/ja active Active
- 2008-02-01 CA CA2845292A patent/CA2845292C/en active Active
- 2008-02-01 TW TW097104110A patent/TWI404538B/zh active
- 2008-02-01 AU AU2008214084A patent/AU2008214084C9/en active Active
- 2008-02-01 AR ARP080100429A patent/AR065138A1/es unknown
- 2008-02-01 CN CN200880003873A patent/CN101641105A/zh active Pending
-
2009
- 2009-07-30 IL IL200173A patent/IL200173A/en active IP Right Grant
-
2010
- 2010-05-10 HK HK10104537.0A patent/HK1138512A1/xx unknown
-
2012
- 2012-02-02 IL IL217891A patent/IL217891A/en not_active IP Right Cessation
-
2013
- 2013-04-24 US US13/869,911 patent/US10058570B2/en active Active
- 2013-05-07 JP JP2013097681A patent/JP5825611B2/ja active Active
- 2013-11-05 IL IL229255A patent/IL229255A/en active IP Right Grant
- 2013-11-21 RU RU2013151904A patent/RU2665362C2/ru active
-
2014
- 2014-10-14 JP JP2014209816A patent/JP5853347B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR065138A1 (es) | Uso de compuestos de arsenico para el tratamiento del dolor y la inflamacion | |
| AR060089A1 (es) | Tratamiento del dolor | |
| HN2011001593A (es) | Piridiloxi-indoles del vegf-r2 y uso de los mismos para el tratmiento de enfermedades | |
| BR112014004845A2 (pt) | pelo menos uma entidade química; pelo menos um composto; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada | |
| EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
| CU20070203A7 (es) | Composición farmacéutica que comprende una difenilurea sustituida con omega-carboxiarilo para el tratamiento del cáncer | |
| CO7101246A2 (es) | Compuesto de carbamato y preparación y uso de los mismos | |
| PA8627601A1 (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-ilo]-(4-bromo-3-metil-5-propoxi-tiofen-2-ilo)-metanona hidrocloruro como un inhibidor de triptasa de mastocitos | |
| AR069490A1 (es) | Agonistas de los receptores de glucocorticoides | |
| UY29412A1 (es) | Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos. | |
| HRP20220068T1 (hr) | Staphylococcus aureus leukocidini, terapijski pripravci, i njihova uporaba | |
| CL2022003143A1 (es) | Conjugados de anticuerpo y fármaco de amatoxina y usos de los mismos (divisional solicitud patente 202102780) | |
| BRPI0506493A (pt) | combinações terapêuticas | |
| BRPI0520167A2 (pt) | formulaÇÕes aprimoradas de fenofibrato contendo mentol ou uma mistura de peg/poloxÂmero | |
| BR112012013252A2 (pt) | composição farmacêutica tópica, preservativo, composto, e, uso do mesmo | |
| EA201170190A1 (ru) | Фармацевтическая композиция, содержащая экстракт мозга свиньи | |
| BR112017017211A2 (pt) | composto, composição, sal farmaceuticamente aceitável de um composto, combinação, formulação farmacêutica, métodos para matar uma micobactéria e/ou inibir a replicação de micobactérias que causam doença em um animal, para tratamento de uma infecção micobacteriana em um animal e para tratamento de uma doença resultante de uma infecção por micobactéria de um mamífero, e, uso de um composto. | |
| UY37577A (es) | Dihidroimidazopiridindionas sustituidas | |
| ECSP22040362A (es) | Derivados de 1,2,4oxadiazol como agonistas del receptor hepático x | |
| AR077987A1 (es) | Combinacion farmaceutica que comprende 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol o 6-dimetilaminometil-1-(3-hidroxifenil)-ciclohexano-1,3-diol y un antiepileptico | |
| PE20100154A1 (es) | Pregn-4-en-21,17-carbolactonas sustituidas en el anillo c, asi como preparados farmaceuticos que las contienen | |
| ATE556134T1 (de) | Mesenchymstammzellen und verwendungendafür | |
| AR048806A1 (es) | Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio | |
| BRPI0409139A (pt) | combinação de ingredientes ativos de óleos que contêm ácido graxo w3 com extratos de plantas que contêm polifenol e uso destes | |
| AR083095A1 (es) | Cocristal de aprepitant l-prolina y composicion farmaceutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |